Natural leukocyte interferon alpha (Alfaferone) combined with ribavirin in the treatment of patients with HCV-related cirrhosis: our experience-Reference-Cited by-同舟云学术

Natural leukocyte interferon alpha (Alfaferone) combined with ribavirin in the treatment of patients with HCV-related cirrhosis: our experience

Published:2011-07-08 Issue:5 Volume:39 Page:433-437
ISSN:0300-8126
Container-title:Infection
language:en
Short-container-title:Infection

Author:

Kozielewicz D.,Dybowska D.,Halota W.,Dróżdż W.

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://www.springerlink.com/index/pdf/10.1007/s15010-011-0135-3

Reference18 articles.

1. Ghany MG, Strader DB, Thomas DL, et al. Diagnosis, management and treatment of hepatitis C: an update. Hepatology. 2009;49:1335–74.

2. Dusheiko G. Thrombopoietin agonists for the treatment of thrombocytopenia in liver disease and hepatitis C. Clin Liver Dis. 2009;13:487–501.

3. Osterborg A. Patients treated with natural (leukocyte-derived) interferon-alpha do not develop IFN antibodies (letter). Eur J Haematol. 1991;47:234.

4. Łapiński TW, Dąbrowska MM, Flisiak R. Leukocytarny interferon naturalny alfa (IFN-άN3) w leczeniu chorych przewlekle zakażonych HCV. Zakażenia. 2008;1:63–7.

5. Cacopardo B, Nunnari G, Benanti F, et al. Leukocyte interferon alpha early retreatment for Child A HCV genotype 1b-infected cirrhotics intolerant to pegylated interferons. Infection. 2009;37:210–5.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral kinetics during the first weeks of pegylated interferon and ribavirin treatment can identify patients at risk of relapse after its discontinuation: new strategies for such patients?;Infection;2011-11-18